Ping Capital Management Inc. raised its holdings in ARK Genomic Revolution ETF (BATS:ARKG – Free Report) by 7.1% in the fourth quarter, Holdings Channel.com reports. The fund owned 15,000 shares of the company’s stock after acquiring an additional 1,000 shares during the quarter. Ping Capital Management Inc.’s holdings in ARK Genomic Revolution ETF were worth $353,000 as of its most recent SEC filing.
Several other hedge funds also recently modified their holdings of ARKG. Sanctuary Advisors LLC bought a new position in ARK Genomic Revolution ETF during the second quarter valued at about $222,000. Dynamic Advisor Solutions LLC lifted its position in ARK Genomic Revolution ETF by 7.8% during the 3rd quarter. Dynamic Advisor Solutions LLC now owns 13,590 shares of the company’s stock worth $348,000 after acquiring an additional 989 shares during the last quarter. Brown Miller Wealth Management LLC lifted its position in shares of ARK Genomic Revolution ETF by 5.5% during the 3rd quarter. Brown Miller Wealth Management LLC now owns 17,974 shares of the company’s stock worth $460,000 after purchasing an additional 933 shares during the last quarter. Elmwood Wealth Management Inc. increased its position in ARK Genomic Revolution ETF by 39.7% in the 3rd quarter. Elmwood Wealth Management Inc. now owns 57,766 shares of the company’s stock worth $1,479,000 after buying an additional 16,412 shares during the period. Finally, Summit Investment Advisory Services LLC bought a new stake in shares of ARK Genomic Revolution ETF in the third quarter valued at approximately $417,000.
ARK Genomic Revolution ETF Price Performance
BATS ARKG opened at $26.85 on Wednesday. The company has a fifty day moving average of $25.31 and a 200-day moving average of $25.20.
ARK Genomic Revolution ETF Profile
The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.
Featured Stories
- Five stocks we like better than ARK Genomic Revolution ETF
- Comparing and Trading High PE Ratio Stocks
- Rocket Lab’s Growth Strategy: Small Rockets, Massive Potential
- Following Congress Stock Trades
- Goldman Sachs vs. Morgan Stanley—Which Stock Has More Upside?
- Are Penny Stocks a Good Fit for Your Portfolio?
- 3 Reasons Bulls Will Win on Super Micro Computer Stock
Want to see what other hedge funds are holding ARKG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ARK Genomic Revolution ETF (BATS:ARKG – Free Report).
Receive News & Ratings for ARK Genomic Revolution ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ARK Genomic Revolution ETF and related companies with MarketBeat.com's FREE daily email newsletter.
